Uses of cyclic adenosine monophosphate or derivatives thereof in omental hemorrhage after surgical operation
An adenosine phosphate derivative and cyclic adenosine monophosphate technology, applied in the field of cyclic adenosine monophosphate or its derivatives, can solve the problems of slow hemostatic effect, life-threatening patients, etc. The effect of reducing the degree of damage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] 1. Main materials
[0027] Cyclic adenosine monophosphate (purchased from Shanghai Yuanye Biotechnology Co., Ltd.), normal saline, distilled water, syringe, optical microscope, homogenizing glass dish, and surgical instruments.
[0028] 2. Subjects
[0029] Adult male rats (purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.), male, weighing 280-350 g, were reared in a single cage before surgery, kept at a body temperature of 18-22 degrees Celsius, free to eat and drink, and raised in a quiet, dark environment .
[0030] 3. Experimental method
[0031] Adult healthy rats were divided into four groups as follows:
[0032] Operation group A: 10 rats, oppressed or knotted to block the blood vessels of intestinal blood, after 5 minutes, intestinal subomentum hemorrhage, did not relieve the oppressed or knotted, and then injected 2ml cyclic adenosine monophosphate solution (2mg cyclic adenosine monophosphate Adenosine was dissolved in 2ml0.9% so...
Embodiment 2
[0040] This embodiment uses cyclic adenosine monophosphate meglumine to replace cyclic adenosine monophosphate, adopts the main materials of embodiment 1, the same experimental object of embodiment 1, and adopts the operation group A and control group B in the experimental method in embodiment 1 Experimental method to obtain the relationship between the amount of bleeding over time, such as image 3 shown.
Embodiment 3
[0042] This embodiment uses dibutyryl cyclic adenosine phosphate calcium to replace cyclic adenosine monophosphate, adopts the main materials of embodiment 1, the same experimental objects of embodiment 1, and adopts the experiment of operation group A and control group B in the experimental method in embodiment 1 method to obtain the relationship between the amount of bleeding over time, such as Figure 4 shown.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com